Accenture delivered a third-quarter fiscal 2026 print that looks orderly on the surface and uncomfortable underneath. Revenues of $18.72 billion rose 6% in U.S. dollars and 3% in local currency, beating the midpoint of management's own $18.35-19.0 billion guide, while diluted earnings per share of $3.80 climbed 9% year over year and operating margin expanded 20 basis points to 17.0%. Free cash flow of $3.6 billion in the quarter and $8.2 billion returned to shareholders year to date are the cash machine doing what it does. The story underneath is the one the equity is being repriced on: new bookings of $19.3 billion declined 2% in U.S. dollars and 3% in local currency, the second consecutive quarter of contraction, and management simultaneously narrowed full-year local-currency revenue growth guidance to 3% to 4% from 3% to 5% on the back of an estimated 1% drag from the U.S. federal business.
The thesis the next six months test is whether Accenture can convert a record pipeline of 104 quarterly client bookings of $100 million or more, up 13% year to date, into the 5%-plus local-currency growth the multiple historically assumes, or whether bookings have rolled over into a structural step-down. The stock closed at $179.82 on August 11, 2026, near the midpoint of a 52-week range of $118.15 to $291.09, with a market capitalization of roughly $110 billion on 612 million shares outstanding, valuing the franchise at approximately 1.6x trailing sales and 13.1x trailing earnings. The risk is that bookings are the leading indicator and revenue is the lagging one, and the gap between them is the only question that matters.